These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26560730)

  • 21. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia.
    Galton CJ; Gomez-Anson B; Antoun N; Scheltens P; Patterson K; Graves M; Sahakian BJ; Hodges JR
    J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):165-73. PubMed ID: 11160463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.
    Geroldi C; Pihlajamäki M; Laakso MP; DeCarli C; Beltramello A; Bianchetti A; Soininen H; Trabucchi M; Frisoni GB
    Neurology; 1999 Nov; 53(8):1825-32. PubMed ID: 10563634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.
    Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P
    Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative regional validation of the visual rating scale for posterior cortical atrophy.
    Möller C; van der Flier WM; Versteeg A; Benedictus MR; Wattjes MP; Koedam EL; Scheltens P; Barkhof F; Vrenken H
    Eur Radiol; 2014 Feb; 24(2):397-404. PubMed ID: 24092044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.
    Möller C; Dieleman N; van der Flier WM; Versteeg A; Pijnenburg Y; Scheltens P; Barkhof F; Vrenken H
    J Alzheimers Dis; 2015; 44(2):635-47. PubMed ID: 25322925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
    Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
    Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease.
    Bocti C; Rockel C; Roy P; Gao F; Black SE
    Dement Geriatr Cogn Disord; 2006; 21(5-6):364-72. PubMed ID: 16534206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.
    Pereira JB; Cavallin L; Spulber G; Aguilar C; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Aarsland D; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2014 Mar; 275(3):317-30. PubMed ID: 24118559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
    Grossman M; Farmer J; Leight S; Work M; Moore P; Van Deerlin V; Pratico D; Clark CM; Coslett HB; Chatterjee A; Gee J; Trojanowski JQ; Lee VM
    Ann Neurol; 2005 May; 57(5):721-9. PubMed ID: 15852395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Ambikairajah A; Devenney E; Flanagan E; Yew B; Mioshi E; Kiernan MC; Hodges JR; Hornberger M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):226-34. PubMed ID: 24533506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images.
    Kitagaki H; Mori E; Yamaji S; Ishii K; Hirono N; Kobashi S; Hata Y
    Radiology; 1998 Aug; 208(2):431-9. PubMed ID: 9680572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population.
    Monge-Argilés JA; Gasparini-Berenguer R; Gutierrez-Agulló M; Muñoz-Ruiz C; Sánchez-Payá J; Leiva-Santana C
    Biomed Res Int; 2016; 2016():1390620. PubMed ID: 27092308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain atrophy in frontotemporal dementia.
    Frisoni GB; Beltramello A; Geroldi C; Weiss C; Bianchetti A; Trabucchi M
    J Neurol Neurosurg Psychiatry; 1996 Aug; 61(2):157-65. PubMed ID: 8708683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease.
    Wang S; Zhang J; Pan T;
    Neurosci Lett; 2018 Oct; 685():109-113. PubMed ID: 30144541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the association between AD biomarkers and cognitive decline.
    Koran MEI; Wagener M; Hohman TJ;
    Brain Imaging Behav; 2017 Feb; 11(1):205-213. PubMed ID: 26843008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.